ArticleCancer medicine2018
YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR
Zhang Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleCancer medicine2018
Zhang Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.